CNETS Canada is committed to improving the quality of life and survival for NET patients across Canada and in support of this vision introduced a new Research Funding Framework in 2016. The 2018 NET Research Grant will provide grant-in-aid for three projects up to a maximum of $40,000 per project. The third NET Research Grant was made possible thanks to the tremendous fundraising efforts of Bailey and Jonathan Daniels. In their honour, this NET research grant will be named The Daniels Constellation Grant for Neuroendocrine Cancer Research.
The NET research funding priorities were determined through consultation with the NET patient community, and input from CNETS Canada’s Scientific and Medical Advisory Board (SMAB). To be eligible for the 2018 NET Research Grant, the project must be a clinical trial or a clinical or fundamental research project (including animal or cellular models) to examine issues relevant for the diagnosis and treatment of Neuroendocrine tumours (NETs).
And the selected grant recipients are:
Cognitive assessment of GI NET patients with carcinoid syndrome by Dr. Rachel Goodwin, Medical Oncologist from Ottawa Hospital Research Institute (OHRI);
Laying the groundwork for a simple microRNA-based blood test to diagnose and monitor all neuroendocrine tumors by Dr. Neil Renwick, Clinician Scientist, Pathology & Molecular Medicine from Queen’s University/Kingston Health Science Center, and
Extending immunotherapy to NET patients with radiotherapy: A correlative study, by Dr. Sten Myrehaug
Physician, Radiation Oncology from Odette Cancer Centre, Sunnybrook Health Sciences